SPC Life Sciences IPO: SPC Life Sciences are a chemical manufacturing firm driven by research and development (R&D) with an emphasis on long-chain multi-stage processes. Their advanced pharmaceutical intermediates, or Pharma Intermediates, are used in a number of expanding therapeutic areas, such as anti-depressants, cardiovascular, vasodilators (anti-platelet), and anti-psychotics.
SPC Life Sciences IPO Overview
| SPC Life Sciences Limited Company Overview | |
|---|---|
| Company Name | SPC Life Sciences Limited |
| IPO Opening Date | November, 2023 |
| IPO Closing Date | November, 2023 |
| Face Value | 10₹ Per Share |
| Share Price Range | [.]₹ – [.]₹ Per Share |
| Lot Size | To Be Announced |
| GMP | Check Here |
| Issue Type | Fresh Issue |
| Total IPO Issue Size | 8,938,870 Shares (Approx) |
| Fresh Issue Size | ₹300 Crores |
| IPO Listing At | NSE And BSE |
| Share Holding Pre Issue | To Be Announced |
| Share Holding Post Issue | To Be Announced |
| More IPO’s | Check Here |
SPC Life Sciences IPO Lot Size
Investors may make a minimum offer of [.] shares and an amount greater than that. The minimum and highest investments made by retail investors and HNI in terms of shares and money are shown in the table below.
| SPC Life Sciences Limited IPO Lot Size | |
|---|---|
| Minimum Retail Applications | 01 Lot |
| Maximum Retail Applications | 13 Lots |
| Minimum S-HNI Applications | 01 Lot |
| Maximum S-HNI Applications | 14 Lots |
| Maximum B-HNI Applications | 68 Lots |
| Total Shares In Single Lot | [.] Shares |
| Amount For Single Lot | ₹ |
SPC Life Sciences IPO Time Table (Tentative)
The IPO for SPC Life Sciences starts on November, 2023, and ends on November, 2023.
| SPC Life Sciences Limited IPO Time Table Complete Details | |
|---|---|
| IPO Initiation Date | November, 2023 |
| IPO Ending Date | November, 2023 |
| Basis Of Allotment | November, 2023 |
| Initiation Of Refund | November, 2023 |
| Shares Credit To Demat Account | November, 2023 |
| Date Of Listing | November, 2023 |
| Cut Off Time For UPI Mandate Confirmation | 05:00 PM, November, 2023 |
SPC Life Sciences IPO Reservation Details
| SPC Life Sciences Limited IPO Reservation Overview | |
|---|---|
| Shares Offered To Retailers | Not Less Than 35% Of Net Offer |
| Shares Offered To HNI | Not Less Than 15% Of Net Offer |
| Shares Offered To QIB | Not More Than 50% Of Net Offer |
SPC Life Sciences Company Financials
| SPC Life Sciences Limited Company Financials Information | |
|---|---|
| This Data Is Of | 31 March, 2023 |
| Total Revenue | 146.44 |
| Assets | 61.48₹ Per Equity Share |
| Profit After Tax | N/A |
| Net Worth | N/A |
| Reserves And Surplus | N/A |
| Debt | N/A |
| All Amount In ₹ Lakh/Crore | |
SPC Life Sciences Promoters Holding
| Share Holding Pre Issue | % |
| Share Holding Post Issue | % |
SPC Life Sciences Key Performance Indicators
| SPC Life Sciences Limited Key Performance Indicators | |
|---|---|
| KPI | Values |
| Post P/E (X) | N/A |
| EPS | 4.30 |
| RoNW | 28.00% |
Is SPC Life Sciences IPO Contact Details.
| SPC Life Sciences Limited Contact Details | |
|---|---|
| Company Address | SPC Life Sciences Limited 284/1, 2 & 3, GIDC Estate, Makarpura, Vadodara |
| Phone | +91 2652658894 |
| cs@spcls.co.in | |
| Website | https://www.spcls.co.in/ |
Is SPC Life Sciences IPO Good Or Bad To Buy?
One of the top producers of advanced intermediates in India for a number of important APIs is SPC Life Sciences. These APIs include pentoxifylline, amiodaroneHCL, ciprostazol, trazodone, tramadol, and paroxetine.
Some of these products have a substantial market share in India and around the world. They can create Pharma Intermediates and collaborate with pharmaceutical firms that are looking for US FDA-compliant manufacturing facilities to be a part of their supply chain because they have a facility that is approved by the US FDA for 6-Chloro-Hexane-2-One.
What Is The Future Of SPC Life Sciences Stock?
They make research and development investments in order to establish a sustainable edge over their rivals. They have an internal R&D facility at GIDC, Makarpura, Vadodara, in addition to their production sites in Ankleshwar and Dahej (R&D Facility). Research and development center occupies 1,390.46 square meters overall and is furnished with an analytical development laboratory (ADL), infrastructure for research and development, specifications freezing, and the development of an analytical method for Key Starting Material (KSM), in-process intermediates, final products, and other raw materials.
What Is The Objective Of SPC Life Sciences IPO Issue?
The main objective’s of SPC Life Sciences IPO issue are :-
- Prepayment or payback of some outstanding loans that our company has taken out.
- Financing needed for our company’s capital expenditure needs as we build up Phase 2 at our Dahej facility to increase the range of pharmaceutical intermediate products offer.
- Meeting the needs for working capital.
- General company objectives
How To Apply For SPC Life Sciences IPO?
The SPC Life Sciences IPO application form and payment can both be completed online. Through the net banking feature of your bank account, you can access the ASBA IPO application. UPI IPO applications are provided by brokers who do not offer banking services. On this page, you can get more details on how to apply for an IPO online using Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank, and SBI Bank.
When Is SPC Life Sciences IPO Allotment?
The Allotment Date For SPC Life Sciences IPO Is November, 2023.